Cargando…
Protective effects of GV1001 on myocardial ischemia-reperfusion injury
The potential cardioprotective effects of the novel vaccine peptide GV1001 were evaluated in myocardial ischemia-reperfusion injury induced rat models. GV1001 is a human telomerase reverse transcriptase derived peptide, which has been reported to possess both anti-tumor and anti-inflammatory effects...
Autores principales: | Chang, Ji-Eun, Kim, Hyun Jun, Jheon, Sanghoon, Lim, Cheong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865859/ https://www.ncbi.nlm.nih.gov/pubmed/28944828 http://dx.doi.org/10.3892/mmr.2017.7528 |
Ejemplares similares
-
Neuroprotective Effects of GV1001 in Animal Stroke Model and Neural Cells Subject to Oxygen-Glucose Deprivation/Reperfusion Injury
por: Kwon, Hyuk Sung, et al.
Publicado: (2021) -
The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma
por: Park, Joo Kyung, et al.
Publicado: (2016) -
Novel Peptide Vaccine GV1001 Rescues Hearing in Kanamycin/Furosemide-Treated Mice
por: Kim, Shin Hye, et al.
Publicado: (2018) -
The Telomerase-Derived Anticancer Peptide Vaccine GV1001 as an Extracellular Heat Shock Protein-Mediated Cell-Penetrating Peptide
por: Kim, Hong, et al.
Publicado: (2016) -
GV1001 Inhibits the Severity of the Ligature-Induced Periodontitis and the Vascular Lipid Deposition Associated with the Periodontitis in Mice
por: Kim, Sharon Y., et al.
Publicado: (2023)